An advanced metastatic breast cancer patient successfully treated with combination therapy including docetaxel, doxorubicin and cyclophosphamide (TAC) as salvage therapy |
| |
Authors: | Sato Yasushi Takayama Tetsuji Sagawa Tamotsu Sato Tsutomu Okamoto Kumiko Takahashi Shou Abe Seiichiro Iyama Satoshi Murase Kazuyuki Kato Junji Niitsu Yoshiro |
| |
Institution: | Fourth Dept. of Internal Medicine, Sapporo Medical University School of Medicine, Japan. |
| |
Abstract: | We reported here a case of advanced breast cancer successfully treated with combination therapy including docetaxel, doxorubicin and cyclophosphamide (TAC) as salvage therapy. A 56-year-old male was referred to our hospital for treatment of recurrent metastatic breast cancer. When he was admitted, his general condition was poor due to massive intraperitoneal metastasis. We administered TAC chemotherapy (docetaxel 75 mg/m(2), doxorubicin 50 mg/m(2), and cyclophosphamide 500 mg/m(2), every 3 weeks). During chemotherapy, he showed no major adverse effects except grade 3 neutropenia, which could be easily managed with G-CSF administration. Metastatic lesions almost disappeared after 4 cycles of TAC. TAC therapy was considered to be acceptable as salvage therapy for a metastatic male breast cancer patient. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|